Company intelligence
Illumina
Unlocking the Power of the Genome
About Illumina
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
Verified activity
Signals from Illumina
43 published signals
Presence & Recognition
Illumina's first rare disease customer is participating in a webinar.
Reported by Kyle Cutler
Presence & Recognition
Illumina participated in the upcoming European Coalition for Comprehensive Genomic Profiling (ECGP) session during ECP 2026 to discuss the meaning of Comprehensive Genomic Profiling (CGP) and its value to payers.
Reported by Luigia Bufi
Presence & Recognition
Illumina is hosting a webinar on environmental DNA and next-generation sequencing for eDNA analysis on Wednesday, 16 September 2026.
Reported by Jennifer Lienen
Presence & Recognition
Illumina is hosting an upcoming Tech Support webinar titled Introduction to Illumina Single Cell 3' RNA Prep on 9th September 2026
Reported by Jennifer Lienen
Presence & Recognition
Illumina will be exhibiting at BioTechX 2026 from 6 to 8 October.
Reported by Jennifer Lienen
Presence & Recognition
Illumina will be exhibiting at BioTechX 2026 from 6 to 8 October.
Reported by Jennifer Lienen
Research & Knowledge
Illumina published a new blog article tracing the path from raw single-cell RNA-seq count matrices to cell type assignments, differential expression results, and pathway-level hypotheses.
Reported by Jennifer Lienen
Presence & Recognition
Illumina is hosting a webinar on environmental DNA and next-generation sequencing for eDNA analysis on Wednesday, 16 September 2026.
Reported by Emeric ROUX
Presence & Recognition
Illumina is hosting an upcoming Tech Support webinar titled Introduction to Illumina Single Cell 3' RNA Prep on 9th September 2026
Reported by Ismahen Ammar-Tekaya
Presence & Recognition
Illumina is hosting an upcoming Tech Support webinar titled Introduction to Illumina Single Cell 3' RNA Prep on 9th September 2026
Reported by Fran Apers
Presence & Recognition
Illumina is hosting an upcoming Tech Support webinar titled Introduction to Illumina Single Cell 3' RNA Prep on 9th September 2026
Reported by Sam Hamlett
Presence & Recognition
Illumina teams will be present at BeSHG/NVHG 2026 to share new developments, exchange ideas, and connect with the genetics community.
Reported by Hatice Barutci
People
Illumina is hiring for a high-performing sales team with the passion for improving human health through the power of genomics.
Reported by Bryan Bartlett
People
Illumina worked on an executive search project with TA colleagues across the US and Singapore.
Reported by Jennifer Baldassarre
Products & Services
Illumina launched StrataMap, a spatial transcriptomics solution featuring 7.5 cm² tissue area, poly(A)-based whole transcriptome profiling, single cell resolution, leading sensitivity, and an end-to-end solution from one provider.
Reported by Lukas Paul
Presence & Recognition
Illumina is hosting an upcoming Tech Support webinar titled Introduction to Illumina Single Cell 3' RNA Prep on 9th September 2026
Reported by Lukas Paul
Presence & Recognition
Illumina is offering expert-led hands-on sessions to try out its oncology analysis tools.
Reported by Alison Selle
Presence & Recognition
Illumina is hosting a handful of small oncology analysis roadmap previews run by VP of Oncology Software, Jing Gao and Dir Oncology TPM Mark W. Mooney in Sweden.
Reported by Alison Selle
People
Illumina is hiring for a new opening on the team.
Reported by Andrew Fuhs
Operations & Supply
Illumina processed 800lbs of bell peppers across San Diego to provide food to community members and farm animals.
Reported by Misty Dixon
Presence & Recognition
Illumina received a recognition award reflecting the passion, dedication, and impact delivered by all involved.
Reported by Olivia Hope
Products & Services
Illumina launched Illumina StrataMap Spatial, making whole-transcriptome spatial discovery more accessible without requiring capital equipment.
Reported by Rajendra Kumar Chauhan, PhD
Presence & Recognition
Illumina is hosting a webinar on environmental DNA and next-generation sequencing for eDNA analysis on Wednesday, 16 September 2026.
Reported by Femke Sinnema
Research & Knowledge
Illumina applied StrataMap Spatial in Dr. Brendan Keating's pig-to-human xenotransplantation research to interrogate transcripts in mixed species samples.
Reported by Steven Barnard